An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...

A new method, developed by Penn State researchers, can test the activity of thousands of RNA enzymes, called ribozymes, in a ...

Based on a validated model of colorectal cancer screening, cell-free DNA blood tests may deliver net benefit when screening ...

Officinae is a provider of precision DNA and RNA services through an AI-driven digital platform ... we took a GAAP noncash goodwill impairment charge of $154 million as we revisited our long-term ...

Scientists monitor mpox virus mutations and human-to-human transmission, impacting vaccination strategies in Africa.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Colorectal cancer screening is important to prevent CRC-related death. New blood and stool tests show promising results.

This enabled UMAMI to evolve its capabilities to offer pathogen testing and vertically integrate Arbiter into its business model. Arbiter’s testing technology simplifies DNA/RNA analysis through a ...

This was discovered from DNA and RNA sequencing from patient tumor samples ... researchers created a mouse model to try to ...